Does bisoprolol reduce the incidence of CHF and/or COPD exacerbation compared with carvedilol in congestive heart failure patients with chronic obstructive pulmonary disease?
In patients with concurrent heart failure and COPD, the use of a selective beta-blocker like bisoprolol may be preferable to carvedilol to reduce the incidence of exacerbations.
These findings support the recommendations to use β-blockers in HF patients with COPD. Importantly, bisoprolol reduced the incidence of CHF and/or COPD exacerbation compared with carvedilol.
Kubota et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: